The Breast Cancer Sessions: a focus on the St. Gallen Consensus

At the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned St. Gallen International Consensus Session on the optimal treatment of early breast cancer.  In this podcast, St. Gallen Consensus Session Co-Chair Giuseppe Curigliano, MD, PhD, European Institute of Oncology & University of Milan, Milan, Italy, is joined by consensus panelists Lisa Carey, MD, FASCO, The University of North Carolina at Chapel Hill, NC, Hope Rugo, MD, FASCO, University of California, San Francisco, CA, and Fatima Cardoso, MD, Champalimaud Clinical Center, Lisbon, Portugal. Tune in to hear the expert panel discuss the key takeaways from the consensus session and the remaining challenges in early breast cancer care. They offer their perspectives on the role of pathologic complete response (pCR) in the post-neoadjuvant setting, gene signature assays for chemotherapy in pre- and post-menopausal women, neoadjuvant treatment in triple-negative and HER2-positive breast cancer, as well as the role of CDK4/6 inhibitors in the adjuvant setting.